PAM
NERV icon

Panagora Asset Management’s Minerva Neurosciences NERV Stock Holding History

Panagora Asset Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-226
Closed -$4K – 2143
2021
Q2 		$4K Hold
226
– – ﹤0.01% 2534
2021
Q1 		$5K Sell
226
-111
-33% -$2.77K ﹤0.01% 2581
2020
Q4 		$6K Buy
337
+225
+201% +$5.67K ﹤0.01% 2421
2020
Q3 		$3K Buy
+112
New +$3.03K ﹤0.01% 2550

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Panagora Asset Management's NERV Position: Q3 2021 in Review

Panagora Asset Management sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 226 shares — an estimated $4K sold.

Panagora Asset Management first reported a position in NERV in Q3 2020 and held it in 4 quarters. The position peaked at $6K in Q4 2020. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • Panagora Asset Management reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 226 Minerva Neurosciences shares in Q3 2021, an estimated $4K.
  • Panagora Asset Management first reported a position in Minerva Neurosciences in Q3 2020 and held it in 4 quarters.
  • Panagora Asset Management's Minerva Neurosciences position peaked at $6K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.